EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protein destabilization underlies pathogenic missense mutations in ARID1B

Fanny Mermet-Meillon, Samuele Mercan, Beatrice Bauer-Probst, Cyril Allard, Melusine Bleu, Keith Calkins, Judith Knehr, Marc Altorfer iD, Ulrike Naumann iD, Kathleen Sprouffske iD, Louise Barys, Fabian Sesterhenn iD und 1 weitere

Nature Structural & Molecular Biology · 2024-07 · 31 (7) · 1018-1022

DOI: 10.1038/s41594-024-01229-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Structural & Molecular Biology, online erschienen am 12.02.2024. Verfasst von Fanny Mermet-Meillon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland. Hauptthemen laut MEDLINE: Mutation, Missense, DNA-Binding Proteins, Transcription Factors, Micrognathism. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ARID1B is a SWI/SNF subunit frequently mutated in human Coffin–Siris syndrome (CSS) and it is necessary for proliferation of ARID1A mutant cancers. While most CSS ARID1B aberrations introduce frameshifts or stop codons, the functional consequence of missense mutations found in ARID1B is unclear. We here perform saturated mutagenesis screens on ARID1B and demonstrate that protein destabilization is the main mechanism associated with pathogenic missense mutations in patients with Coffin–Siris Syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mutation, MissenseDNA-Binding ProteinsTranscription FactorsMicrognathismProtein StabilityHand Deformities, CongenitalIntellectual DisabilityHumansAbnormalities, MultipleFaceNeck

Substanzen

DNA-Binding ProteinsTranscription FactorsARID1B protein, human

Autor:innen und Institutionen

  • Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland.
  • Disease Area Immunology, Novartis Biomedical Research, Basel, Switzerland.
  • Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland.
  • Discovery Sciences, Novartis Biomedical Research, Basel, Switzerland. fabian.sesterhenn@novartis.com.
  • Disease Area Oncology, Novartis Biomedical Research, Basel, Switzerland. giorgio.galli@novartis.com.

ORCID-Profile: Marc Altorfer, Ulrike Naumann, Kathleen Sprouffske, Fabian Sesterhenn, Giorgio G Galli

Zitieren

APA

Mermet-Meillon, F., Mercan, S., Bauer-Probst, B., Allard, C., Bleu, M., Calkins, K., Knehr, J., Altorfer, M., Naumann, U., Sprouffske, K., Barys, L., Sesterhenn, F., & Galli, G. G. (2024). Protein destabilization underlies pathogenic missense mutations in ARID1B. Nature Structural & Molecular Biology, 31(7), 1018-1022. https://doi.org/10.1038/s41594-024-01229-2

Vancouver

Mermet-Meillon F, Mercan S, Bauer-Probst B, Allard C, Bleu M, Calkins K, et al. Protein destabilization underlies pathogenic missense mutations in ARID1B. Nature Structural & Molecular Biology. 2024;31(7):1018-1022. doi:10.1038/s41594-024-01229-2

BibTeX
@article{MermetMeillon2024,
  author = {Mermet-Meillon, Fanny and Mercan, Samuele and Bauer-Probst, Beatrice and Allard, Cyril and Bleu, Melusine and Calkins, Keith and Knehr, Judith and Altorfer, Marc and Naumann, Ulrike and Sprouffske, Kathleen and Barys, Louise and Sesterhenn, Fabian and Galli, Giorgio G},
  title = {Protein destabilization underlies pathogenic missense mutations in ARID1B},
  journal = {Nature Structural & Molecular Biology},
  year = {2024},
  volume = {31},
  number = {7},
  pages = {1018--1022},
  doi = {10.1038/s41594-024-01229-2}
}
Kostenlos starten →